Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Antispasmodic Drotaverine to Shorten the Length of Labor in Nulliparous Women

NCT01639027 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT01639027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Antispasmodic Drotaverine to Shorten the Length of Labor in Nulliparous Women
Lead sponsor
Ain Shams Maternity Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2012
Completion date
January 31, 2013
Enrollment
352 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

failure of cervical dilation as antepartum condition, labor pain, mild birth asphyxia, apgar 4-7, prolonged first stage of labor